Fabius, True compliance does have a time frame however I believe that comes in June. In arguendo lets say sales alone do not get us above the $1 mark, they have the ability to ask for an extension which I believe they go for 6 months, which takes us till the end of the year. At the very least, in that time frame we will have had updates on the HAP studies, re-submission of the application AND the end of October we have the trial for the patent infringement.
So between just those updates (assuming they would be positive) any one those should pop the price above the $1 mark assuming the manipulation has stopped.
personally, I do not see de-listing as being relevant, even if something happens to the generic sales and we do not obtain improved sales. plus in between there, we should be hearing of at least 1 ANDA approval, one would think.
News 
Market Data 
Discover 
AI
